Citigroup slips as investors look past earnings beat to softer quarter-over-quarter profitability
Investivoq PriceTracker
Citigroup (C) is down 3.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The selloff appears tied less to the headline earnings beat and more to signs that profitability cooled from the prior quarter while credit costs edged higher. This could also reflect a cautious read on management commentary as investors weighed higher-rate and inflation risks, along with slower momentum in parts of Wall Street activity.
Details:
Sources:
Citigroup earnings release, SEC, AP News
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$C Insider Trading Activity
$C insiders have traded $C stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $C stock by insiders over the last 6 months:
- EDWARD SKYLER (Hd of Ent Svc & Public Affairs) sold 25,000 shares for an estimated $3,285,349
- NICOLE GILES (CHIEF ACCOUNTING OFFICER) sold 12,732 shares for an estimated $1,678,077
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$C Hedge Fund Activity
We have seen 1,281 institutional investors add shares of $C stock to their portfolio, and 1,061 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 26,121,186 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,655,921,192
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 12,189,179 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,705,997,492
- CAPITAL WORLD INVESTORS removed 7,094,438 shares (-17.4%) from their portfolio in Q2 2026, for an estimated $992,937,542
- ROYAL BANK OF CANADA added 6,761,065 shares (+78.6%) to their portfolio in Q2 2026, for an estimated $946,278,657
- NORGES BANK removed 4,723,296 shares (-19.7%) from their portfolio in Q2 2026, for an estimated $661,072,508
- D. E. SHAW & CO., INC. added 4,592,558 shares (+448.7%) to their portfolio in Q2 2026, for an estimated $642,774,417
- BLACKROCK, INC. removed 4,271,127 shares (-2.8%) from their portfolio in Q2 2026, for an estimated $597,786,934
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$C Congressional Stock Trading
Members of Congress have traded $C stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $C stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR sold up to $15,000 on 09/24.
To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.
$C Price Targets
Multiple analysts have issued price targets for $C recently. We have seen 8 analysts offer price targets for $C in the last 6 months, with a median target of $155.5.
Here are some recent targets:
- Erika Najarian from UBS set a target price of $150.0 on 07/07/2026
- Ebrahim Poonawala from B of A Securities set a target price of $176.0 on 07/07/2026
- Vivek Juneja from JP Morgan set a target price of $149.0 on 07/06/2026
- Glenn Schorr from Evercore ISI Group set a target price of $143.0 on 07/06/2026
- Betsy Graseck from Morgan Stanley set a target price of $164.0 on 06/29/2026
- John McDonald from Truist Securities set a target price of $158.0 on 06/26/2026
- Mike Mayo from Wells Fargo set a target price of $165.0 on 06/18/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.